PFAS Monitoring in the United States and Europe: What Companies Need to Prepare For
Per- and polyfluoroalkyl substances, or PFAS, have become a major compliance issue for manufacturers, importers, water suppliers and downstream product companies. Their persistence, wide industrial use and potential health and environmental effects have led regulators in the United States and Europe to introduce new monitoring duties, reporting requirements and product restrictions.
For businesses, the challenge is no longer limited to determining whether PFAS are intentionally added to a product. Companies increasingly need visibility across raw materials, components, coatings, processing aids, packaging, firefighting systems and waste streams. PFAS compliance is therefore becoming a supply-chain data issue as much as a laboratory-testing issue.
PFAS regulation in the United States
In the United States, PFAS requirements are developing through federal rules and an expanding range of state measures.
The U.S. Environmental Protection Agency has established enforceable drinking-water limits for PFOA and PFOS. EPA has also proposed changes affecting compliance timing and the treatment of several other PFAS, including PFHxS, PFNA and GenX chemicals. Because parts of this framework remain subject to further rulemaking, water systems and affected businesses should continue working toward the existing requirements rather than assuming that proposed changes are final.
Monitoring is becoming a more important operational function. Public water systems may need more frequent sampling where results approach or exceed regulatory thresholds. This increases the need for reliable analytical methods, consistent laboratory records, and traceable data management.
A second major requirement is the Toxic Substances Control Act PFAS reporting rule under Section 8(a)(7). It requires covered manufacturers and importers to report information on PFAS manufactured or imported since 1 January 2011. Relevant information may include chemical identity, volumes, uses, disposal, worker exposure, and available health or environmental data.
The reporting timetable has changed while EPA prepares revisions to the rule. Proposed modifications may affect imported articles, low-concentration mixtures, impurities, by-products, research chemicals, and certain intermediates. Companies should not rely on a proposed exemption before the final rule is published.
Preparation remains essential. Businesses may need to reconstruct many years of purchasing, formulation, and import records. Supplier questionnaires, bills of materials, safety data sheets, declarations, and available test reports should be reviewed now so that data gaps can be addressed before a submission window opens.
PFAS monitoring and restrictions in Europe
Europe is addressing PFAS through drinking-water rules, substance-specific restrictions and the proposed broad restriction under REACH.
Since January 2026, EU Member States have been required to monitor PFAS in drinking water and ensure compliance with the values set under the recast Drinking Water Directive. The framework includes parameters for “PFAS Total” and the “Sum of PFAS”, supported by technical guidance on analytical methods. Where limits are exceeded, authorities and water suppliers may need to take corrective action and inform the public.
The proposed EU-wide REACH restriction remains the most important future measure for companies placing chemicals, mixtures and articles on the European market. ECHA’s scientific committees have continued their assessment of the proposal, including its risk-management options, possible derogations and socio-economic effects.
A general PFAS ban has not yet entered into force. However, companies should already assess where PFAS are used, whether alternatives are available and which applications may depend on transitional periods or derogations. Waiting for the final legal text may leave too little time for testing, supplier engagement or substitution.
Several narrower restrictions are already closer to implementation. The PFHxA restriction under REACH applies to specified uses in products such as textiles, footwear, cosmetics and certain food-contact materials, with different application dates by product category. The EU has also adopted restrictions on PFAS in firefighting foams, with requirements beginning to apply from October 2026.
Why supplier declarations are not enough
A simple “PFAS-free” declaration may provide limited assurance, especially where suppliers lack full knowledge of upstream formulations. PFAS can be present in membranes, fluoropolymers, coatings, inks, seals, lubricants and processing aids several tiers away from the finished product.
A defensible compliance system should connect products, materials, suppliers, substance identities, declarations, test reports, legal requirements, exemptions, deadlines and corrective actions. The objective is not to test every product, but to identify where PFAS are most likely to occur, where evidence is weak and where deadlines create the greatest business risk.
How Advilex can help
Advilex helps companies turn fragmented PFAS information into a structured compliance program. Support can include regulatory monitoring, product and supplier mapping, targeted questionnaires, document review, gap analysis, testing strategies, and escalation procedures.
For companies operating in multiple markets, Advilex can distinguish between requirements that are final, proposed or still under scientific review. It can also help determine what evidence is proportionate, from supplier declarations and material disclosures to analytical testing, contractual warranties, and substitution planning.
What ARCAIS changes in supply-chain monitoring
ARCAIS provides the digital structure needed to manage PFAS compliance across complex supplier networks. The platform can map products to materials and suppliers, distribute questionnaires, collect documents, record approvals, and maintain an audit trail.
Automated alerts can identify missing test reports, expired declarations, affected materials, or approaching deadlines. A regulatory change can be linked directly to the products and suppliers concerned, while higher-risk cases can be escalated for technical review or testing.
This shifts PFAS compliance from a periodic spreadsheet exercise to continuous monitoring. It also preserves the evidence behind each decision, helping companies respond more effectively to regulators, customers, and auditors.
Preparing for the next PFAS deadline
Companies should begin by identifying potentially affected products, confirming relevant jurisdictions, engaging suppliers, and assessing the quality of available evidence. They should also distinguish intentional PFAS use from impurities, residues, and unknown upstream content.
Advilex and ARCAIS can help build these activities into an auditable compliance system, reduce last-minute data collection, and support better substitution and sourcing decisions.
PFAS compliance is no longer a single-substance exercise. It is an ongoing test of whether a company can connect regulatory intelligence with reliable supply-chain information.
This article provides general regulatory information and does not constitute legal advice.
